Abstract. The roles of calmodulin (CaM)-dependent protein kinase II (CaMKII) in the maintenance of basal activity and the reversion of run-down of L-type Ca 2+ channels were studied in guinea-pig ventricular myocytes by the patch-clamp technique. In the cell-attached configuration, the Ca
Introduction
Voltage-gated L-type Ca 2+ channels control diverse physiological functions including gene transcription, rhythmic firing, synaptic transmission, hormone secretion, and excitation-contraction coupling (1) . Electrophysiological studies of the channels are usually carried out with patch-clamp techniques. However, the activity of the L-type Ca 2+ channel decreases when the cytoplasmic side of the channel is perfused with an artificial physiological solution, for example, in whole-cell or inside-out configurations (2) . This phenomenon is referred to as run-down (2) and can be considered as a failure of the mechanism by which basal activity of the channel is maintained (3) . So far, several mechanisms have been suggested for run-down, including proteolysis of the channel and dephosphorylation of the phosphorylation mediated by cAMP-dependent protein kinase (PKA) (2, 4) . Recent work also shows that phosphatidylinositol-4,5-bisphosphate (PIP 2 ) can stabilize the activity of P / Q-type Ca 2+ channels (5, 6) . Alternatively, we have reported that a cytoplasmic extract from cardiac tissue recovers the Ca 2+ channel activity from run-down (3, 7, 8) , suggesting that run-down of the Ca 2+ channel activity may be due to the washout of certain cytoplasmic factors. Subsequently the cytoplasmic factors were identified as calpastatin, ATP, and a yet unidentified factor in a high molecular mass fraction (H fraction) obtained from gel filtration of the cardiac tissue (3, 9, 10) . However, the mechanisms of the maintenance of basal activity and the recovery of the channel activity from run-down by cytoplasmic factors are still unknown.
L-Type Ca 2+ channels are regulated by a variety of second messenger pathways, especially by protein kinases including PKA, cGMP-dependent protein kinase (PKG), and protein kinase C (PKC) (11) . Recent studies have suggested that the Ca 2+ channels are also regulated by CaM-dependent protein kinase II (CaMKII) (12) . A number of different studies have shown that CaMKII may be responsible for the positive feedback, Ca 2+ -dependent facilitation (CDF) (13 -15) . Alternatively, some other studies have proposed that CaM is tethered to the Ca 2+ channel and function as a Ca 2+ sensor for both CDF and Ca
2+
-dependent facilitation inactivation (CDI) of the channels (14, 16, 17) . Therefore, the role of CaMKII in the regulation of Ca 2+ channels still needs further investigation. Our recent study showed that the run-down of L-type Ca 2+ channel in guinea-pig ventricular myocyte was reversed by CaM in the presence of ATP (18) . However, this run-down reversing effect of CaM decreased time-dependently. The reason for this phenomenon has not yet been clarified.
The present study was carried out to investigate a possible role of CaMKII in the maintenance of basal activity and the reversion of run-down of L-type Ca 2+ channels and to explore the relationships among CaMKII, CaM, and cytoplasmic factors in the regulation of Ca 2+ channels. We found that CaMKII inhibitors depressed basal activity in cell-attached patches and cytoplasmic factors-induced recovery from run-down of the Ca 2+ -channel activity in inside-out patches. Furthermore, CaMKII (activated by CaM) recovered the Ca 2+ -channel activity even at 5 min after the start of rundown. We concluded that CaMKII played a crucial role in the maintenance of basal activity of L-type Ca 2+ channels.
Materials and Methods

Preparation of single myocytes
Single ventricular myocytes from guinea-pig hearts were dispersed by collagenase and protease as described previously (19) . Briefly, a female guinea pig (weight: 400 to 600 g) was anaesthetized with pentobarbital sodium (30 mg / kg, i.p.), and the aorta was cannulated in situ under artificial respiration. The heart was then dissected out, mounted on a Langendorf apparatus and perfused with Tyrode solution for 3 min at 37°C, nominally Ca
2+
-free Tyrode solution for 5 min, and a Ca
-free Tyrode solution containing collagenase (0.08 mg / ml; Yakult Pharmaceutical Co., Tokyo) for 10 to 15 min. The heart was then washed out with a high-K + and low-Ca 2+ solution (storage solution) and the ventricular myocytes were dispersed and filtered through a stainless-steel mesh (105 μm). The myocytes were washed twice by centrifugation (800 rpm, 3 min) and kept at 4°C. In some cases, myocytes were treated with protease (type XIV, 0.05 mg / ml; Sigma-Aldrich, St. Louis, MO, USA) and DNase I (type IV, 0.02 mg / ml; Sigma-Aldrich) to improve the success rate in attaining a giga-ohm seal.
Solutions
Tyrode solution contained 135 mM NaCl, 5.4 mM KCl, 0.33 mM NaH 2 PO 4 , 1.0 mM MgCl 2 , 5.5 mM glucose, 1.8 mM CaCl 2 , and 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (Hepes)-NaOH buffer (pH 7.4). The storage solution was composed of 70 mM KOH, 50 mM glutamic acid, 40 mM KCl, 20 mM KH 2 PO 4 , 20 mM taurine, 3 mM MgCl 2 , 10 mM glucose, 10 mM Hepes, and 0.5 mM Ca-ethyleneglycolbis-(β-aminoethylether)-N,N'-tetraacetic acid EGTA, with the pH adjusted to 7.4 using KOH. Pipette solution contained 50 mM BaCl 2 , 70 mM TEA Cl, 0.5 mM EGTA, 0.003 mM Bay K 8644, and 10 mM HepesCsOH buffer (pH 7.4). The basic internal solution consisted of 90 mM K aspartate, 30 mM KCl, 10 mM KH 2 PO 4 , 1 mM EGTA, 0.5 mM MgCl 2 , 0.5 mM CaCl 2 , and 10 mM Hepes-KOH buffer 10 (pH 7.4). This solution is used as the bath solution in the inside-out patches; the free Ca 2+ is 80 nM.
Materials
The agents used in this study were aprotinin and pepstatin A from Boehringer Mannheim, Mannheim, Germany; iodoacetamide from Katayama Seiyakusyo Co., Ltd., Osaka; ATP (Mg salt), Bay K 8644, benzamidine, leupeptin, phenylmethylsulfonyl fluoride (PMSF), KN-62, autocamtide-2-related inhibitory peptide myristoylated (AIP-m), and CaM from Sigma-Aldrich; trypsin from Wako Pure Chemical Industries, Osaka; KN-93, KN-92, Autocamid-2-related inhibitory peptide (AIP), and CaM kinase II inhibitory peptide 281-301 (CIP) from Calbiochem, La Jolla, CA, USA. In the experiments, KN-93, KN-92, and KN-62 were each prepared as stock solutions of 10 mM in DMSO, before use (20) .
Preparation of cytoplasmic fractions
Bovine heart ventricular tissue was homogenized at 4°C in 3 volumes (v / w) of a solution containing 20 mM Tris-Hepes (pH 7.2) and various protease inhibitors (starting buffer). The stock solution of protease inhibitors (×1000 concentration, protease inhibitor cocktail) contained 10 mM benzamidine, 10 mg / ml iodoacetamide, 10 mM PMSF, 2 mg / ml aprotinin, 5 mg / ml leupeptin, and 0.5 mg / ml pepstatin A (3, 8) . The homogenate was centrifuged at 10,000 × g for 20 min and then at 100,000 × g for 30 min. Then the supernatant fraction was filtered through a 0.22-μm millipore filter. The filtrate fractionated by ion exchange chromatography, using a DEAE-5PW column (8 × 75 mm) preequilibrated with the starting buffer (at pH 6.8). The eluted protein at 50 -360 mM KCl was concentrated by ultrafiltration through an Amicon PM30 membrane and applied to gel filtration, using a column of Toyopearl HW 60 (26 × 680 mm) pre-equilibrated with the basic internal solution containing protease inhibitors, at a rate of 4.7 -6 ml / min. The H fraction was the fraction with a molecular mass higher than 300 kDa, while the P fraction was the fraction with a molecular mass of 250 -300 kDa.
Preparation of CaMKII
A rat CaMKIIα cDNA template (generous gift from Dr. E. Miyamoto and Dr. Y. Takeuchi, Kumamoto University, Japan) was amplified by PCR and subcloned into the glutathione S-transferase (GST) fusion protein expressing vector pGEX-6p-1 (GE Healthcare Biosciences, Piscataway, NJ, USA). The vector was transformed into the Escherichia coli strain BL21 (DE3), and the GST-fusioned CaMKII was produced and purified using the Bulk GST Purification Module (GE Healthcare Biosciences). The GST region of the fusion protein was then cut out with PreScission TM Protease (GE Healthcare Biosciences), and the released protein was quantified using the Bradford method.
CaMKII expressed in E. coli shows similar catalytic properties to that purified from rat brain (21) . In the present study, CaMKII (0.3 μM) was mixed with 0.7 μM CaM in the basic internal solution (free Ca 2+ = 80 nM) at room temperature at least 20 min prior to the patchclamp experiments, and CaM was continuously present in the test solution during the application of CaMKII in the patch-clamp experiment. Activity of CaMKII was estimated to be about 40% of the total activity.
Patch-clamp and data analysis
Single L-type Ca 2+ currents were recorded by the patch-clamp technique at room temperature (23°C -25°C) using a patch pipette (2 -4 MΩ) containing 50 mM Ba 2+ and 3 μM Bay K 8644. For the application of the cytoplasmic fractions and other agents to insideout patches, the patch was moved to a small inlet of the perfusion chamber, which was connected to a microinjection system.
Barium currents through the Ca 2+ channels were elicited by depolarizing pulses from −70 to 0 mV for 200-ms duration at a rate of 0.5 Hz, recorded with a patch clamp amplifier (EPC-7; HEKA Elektronik, Lambrecht, Germany), and fed to a computer (PC9801; NEC, Inc., Tokyo) at a sampling rate of 3.3 kHz after being filtered at 1 kHz with a Bessel-type filter (24 dB / oct). The capacity and leakage currents in the current traces were digitally subtracted. The mean current during the period 5 -105 ms after the onset of the test pulses (I) was measured and divided by the unitary current amplitude (i) to yield NPo (since I = N × Po × i), where N is the number of channels in the patch and Po is the time-averaged open-state probability of the channels. Paired and two sample Students t-tests were used to estimate statistical significance, and a P value less than 0.05 was considered as significant.
Results
CaMKII inhibitors depressed basal activity of Ca
2+ channels in cell-attached patches
To investigate a possible role of CaMKII in the maintenance of basal activity of the Ca 2+ channel, we examined the effects of two types of CaMKII inhibitors at different concentrations in the cell-attached configuration of the patch-clamp technique. As a control channel activity, we utilized the averaged NPo of the initial 2 min (60 sweeps), while as a test channel activity in an inhibitor, the averaged NPo in 5 min (150 sweeps) period was taken from 5 min to 10 min after the start of the drug application. As shown in Fig. 1 , A and B, 5 min after the application of KN-93, an inhibitor for CaMKII, the averaged NPo was decreased dose-dependently to 81.8 ± 3.5% (at 1 μM, n = 3, P<0.05) and 26.3 ± 3.8% (at 10 μM, n = 4, P<0.01) of the control value. KN-92 (1 to 10 μM), an inactive KN-93 analogue, had no significant influence on the averaged NPo. The averaged NPo was 98.3 ± 13.6% (at 1 μM n = 3, P>0.05) and 91.7 ± 16.9% (at 10 μM, n = 3, P>0.05) of the control value, respectively (Fig. 1C) , supporting that the effect of KN-93 was mediated by CaMKII inhibition in this experimental condition. AIP-m, which corresponds to the autoinhibitory domain of CaMKII, is a membranepermeable peptide inhibitor highly specific to CaMKII. Although 0.1 μM AIP-m did not have a significant effect, 1 μM AIP-m decreased the averaged NPo significantly to 65.8 ± 10.6% (n = 4, P<0.01) of the control ( Fig. 1: D and E) . The relative channel activity measured at the same time period in the control experiment taken with the basic internal solution containing 0.1% DMSO was 101.3 ± 4.4% (n = 4). Figure 1F summarized the inhibitory effects of CaMKII inhibitors. These results strongly supported the view that CaMKII inhibition in the cardiac myocytes led to a reduction in basal activity of the Ca 2+ channels. In addition to testing with the acute application protocol described above, we examined the effects of KN-93 extensively using a pre-incubation protocol. The cells were pre-incubated for more than 10 min with the internal solution containing no (control) or 1 μM KN-93, and then channel activity was recorded in the cellattached mode for 2 min. As shown in Fig. 2A , the channel activity was lower in the cells pre-incubated with KN-93. The averaged NPo were 0.26 ± 0.04 (n = 28) in the control and 0.12 ± 0.03 (n = 14) in KN-93, showing 54% reduction of the averaged NPo by KN-93 that was statistically significant (P<0.05, Fig. 2B ). The inhibition extent is consistent with the results obtained in acute application described above.
CaMKII inhibitors blocked the recovery of the channel activity induced by cytoplasmic factors in inside-out patches
We have previously found that bovine cardiac tissue extract and the partial purified cytoplasm recovered Ca 2+ channel activity after run-down, suggesting that basal activity of the Ca 2+ channel is maintained by certain cytoplasmic factors. Although it has been determined that the cytoplasmic factors are ATP, calpastatin, and a factor in the high molecular fraction of gel filtration chromatography, the mechanism by which the cytoplasmic factors recover the Ca 2+ -channel activity from run-down is still not clear. In the following experiments, we explored the possibility that CaMKII activation is involved in the reversion of run-down by cytoplasmic factors.
As shown in Fig. 3A , Ca 2+ channel activity was first recorded in the cell-attached configuration, and then run-down of the channel activity was induced by insideout patch formation in the basic internal solution. Application of partially purified cytoplasmic factors (H and P fractions) together with 3 mM ATP recovered the channel activity to 87.1 ± 23.9% (n = 4) of that recorded in the cell-attached configuration. This value is similar to that observed previously: 87 ± 35% in the myocytes and 66 ± 24% in Ca V 1.2 α 1c transfected CHO cells (3, 22) . The effect of CIP was then examined. This peptide contains 21 amino acids corresponding to the residues 281-301 of the CaMKIIα subunit with which 286 threonine was replaced by alanine. As shown in Fig. 3B , CIP (10 μM) inhibited the reversing effect of cytoplasmic factors on the run-down in inside-out patches. The relative NPo in the inside-out patches was only 19.1 ± 4.5% (n = 4) of that in the cell-attached patches, significantly different from the effect of cytoplasmic factors (P<0.05), implying that CaMKII activity is involved in the cytoplasmic factor-induced recovery of the channel activity from run-down.
The effect of KN-62 (another type of CaMKII inhibitor) in the presence of cytoplasmic factor was also examined. In the presence of 0.1 μM KN-62, the recovery of the Ca
2+
-channel activity after run-down in the inside-out patch mode was only 13.2 ± 7.7% (n = 4, figure not shown), showing partial recovery from rundown, similar to the effect of 10 μM CIP. When the concentration of KN-62 was increased up to 1 and then 10 μM, the recovery of the Ca 2+ channel from run-down was further suppressed. In 4 experiments with 1 μM KN-62, only 2 showed brief channel openings, 1.2% and 4.0% of that recorded in the cell-attached mode, respectively. In 4 other experiments with 10 μM KN-62, only one patch showed relative channel activity of 0.1%. These results support the idea that CaMKII activation is involved in the reversion of Ca
-channel run-down by cytoplasmic factors.
CaM-induced recovery of Ca
2+ channel activity is more pronounced in the presence of CaMKII in the late phase of run-down
We have previously found that even without CaMKII, CaM + ATP can recover the channel activity after rundown (18) . However, the effect of CaM + ATP is less pronounced in the late phase of run-down in the previous observation. Together with the present findings that CaMKII activation is involved in the maintenance of basal activity of the Ca 2+ channels, we hypothesized that the time-dependent attenuation of the effect of CaM + ATP might be antagonized by CaMKII. To examine this hypothesis, we did the following experiments. First, we confirmed that when 0.7 μM CaM + 3 mM ATP were applied to the channels 1 min after rundown upon formation of inside-out patch, the channel activity was recovered to 92.5 ± 20.1% (n = 4, Figs. 4A and 6A). However, when applied at 5 min after the patch excision, the recovery of the channel activity became significantly smaller, i.e., 28.2 ± 11.1% (n = 4, P<0.05, Figs. 4B and 6A) . Furthermore, we found that when 0.33 μM CaMKII was applied together with CaM (0.7 μM) + ATP (3 mM), channel activity was recovered to 85.3 ± 14.6% (n = 7) of the control (Figs. 4C and 6A ). This value was not significantly different from that produced by CaM + ATP (P>0.05, Fig. 6A ). On the other hand, when CaMKII + CaM + ATP were applied at 5 min after run-down, the recovery of the channel activity was significantly higher than obtained in CaM + ATP alone, that is, 75.0 ± 15.0% (n = 5, P<0.05, Figs. 4D and 6A) . Thus, although CaMKII had a smaller effect on the action of CaM + ATP at 1 min, it showed a larger effect at 5 min (Fig. 6A) , implying that there might be a slow dephosphorylation during the run-down that could be reversed by phosphorylation induced by 
CaMKII.
CaMKII inhibitors blocked the CaMKII-induced recovery of Ca
2+
-channel activity from run-down We then investigated whether a CaMKII inhibitor could suppress the recovery of the channel activity induced by CaMKII + CaM + ATP. At 1 min after rundown upon the formation of the inside-out patch, the recovery induced by CaMKII + CaM + ATP was not significantly blocked by AIP (10 μM), a CaMKII inhibitor (Fig. 5A ). The relative channel activity was 76.8 ± 20.6% in the presence of 10 μM AIP, not significantly different from that in the absence of AIP (85.3 ± 14.6%, Figs. 4C and 6A). However, at 5 min after run-down, the effect of CaMKII + CaM + ATP was markedly suppressed by the same inhibitor (Fig. 5B) . The relative channel activity was only 4.9 ± 2.2%, significantly different (P<0.01) from that in the absence of 10 μM AIP (75.0 ± 15.0%, Figs. 4D and 6A ). These results suggested that the phosphorylation mediated by exogenous CaMKII is required for the recovery of channel activity from the late phase of run-down.
Discussion
In the present study, we have investigated the roles of CaMKII in the maintenance of basal activity and the reversion of run-down of L-type Ca 2+ channels. In the cell-attached patches, we found that basal activity of the L-type Ca 2+ channel was depressed by CaMKII inhibitors. In the inside-out patches, we found that the cytoplasmic factor-induced recovery of the channel activity from run-down was blocked by CaMKII inhibitors and that CaMKII + CaM + ATP restored the channel activity even at 5 min after the run-down upon the formation of the inside-out patch. Based on these results, we concluded that the maintenance of basal activity of the L-type Ca 2+ channels requires CaMKII activation and that the run-down of L-type Ca 2+ channels is partially attributed to a loss of CaMKII activity.
Basal activity of L-type Ca
2+ channels CaMKII regulates many kinds of ion channels including L-type (12) and T-type Ca 2+ channels (23), EAG-type K + channels (24), Ca
2+
-activated Cl − channels (25) , and ryanodine receptor channels (26) . In cardiac myocytes, CaMKII localizes with L-type Ca 2+ channels (27) and the Ca 2+ -dependent facilitation of the Ca 2+ current has been attributed to CaMKII activity (13 -15) . Furthermore, in cardiac myocytes of the CaMKIIδ c transgenic mouse, peak Ca 2+ current was increased and CaMKII inhibition normalized the Ca 2+ current (28) . In accordance with these findings, we have found in this study that CaMKII inhibitors (KN-93 and AIP-m) depress basal activity of Ca 2+ channels, suggesting that CaMKII activation is involved in the maintenance of basal activity of the L-type Ca 2+ channels. The inhibitory effects of CaMKII inhibitors on basal activity of Ca 2+ channels suggest that in a basal condition, even without any humoral stimulation, a certain site in Ca 2+ channels in the myocytes seems to be already phosphorylated by residual activity of CaMKII. Relevant to this idea, there seems to be a small but significant fraction of CaMKII in a persistently active (phosphorylated) state at physiological intracellular Ca 2+ concentration (29) . If the basal level of Ca 2+ current is regulated by phosphorylation, effects of counteracting protein phosphatase and its inhibitors on the Ca 2+ current may be expected. Accordingly, some reports have shown that protein phosphatases regulate the basal current of Ca 2+ channel (30) . In rat myocytes, protein phosphatase 2A (PP2A) reduces the steady-state L-type Ca 2+ current (31) . In mouse ventricular myocytes, inhibitors of protein phosphatase 1 (PP1) increase the Ca 2+ -channel basal current (32). In guinea-pig ventricular myocytes, inhibitor 2 of PP1 and okadaic acid (inhibitor of PP1 and PP2A) at micromolar concentrations elevate the basal current (30) .
Taken together, it is suggested that there may be a phosphorylation site in the L-type Ca 2+ channel or its associated protein regulating the basal activity of the channel. It is not clear whether this putative phosphorylation site is different from that for up-modulation by PKA.
Mechanism by which cytoplasmic factors restore the run-down channels
We previously found that run-down of L-type Ca channel was reversed by cytoplasmic factors (7 -10) . Subsequently the factors were determined to be ATP, calpastatin, and a factor in the high molecular mass (H) fraction (3, 9, 10, 23) . The effect of calpastatin is confined to its domain L (N-terminal side), but not to the calpain inhibitory domains, domain 1-4 (33, 34). However, the detailed mechanism by which these factors reverse run-down and the nature of the effective compo- 2+ channels. In the basal condition, the channel (or related protein) is phosphorylated (gray circle) and bound with CaM (white circle). When the inside-out patch is formed in the basic internal solution, CaM dissociates from the channel in the early phase (1 min). In the late phase (5 min), the channel is further dephosphorylated. Recovery of channel activity in the late phase requires both CaM binding and CaMKII activity. CaMKII inhibitor expresses its inhibitory effect only in the late phase in which the channel is dephosphorylated, but not in the earlier phase in which the channel is perhaps still in the phosphorylated state.
nent of the H fraction remain to be unmasked.
In the present study, the cytoplasmic factor-induced recovery of Ca 2+ channel activity from run-down was significantly antagonized by CaMKII inhibitors, indicating that CaMKII activation is involved in the effect of the cytoplasmic factors. Thus it is implied that one of the cytoplasmic factors is related to the activation of CaMKII and promotes phosphorylation of either the channels themselves or of certain related proteins that are necessary for recovery of the Ca 2+ channels from run down by an additional factor such as calpastatin. Rundown of the Ca 2+ channels can be considered as a failure of the mechanism by which basal activity of the channel is maintained. Therefore, the results obtained in insideout patches with cytoplasmic factors also support the view that CaMKII activation is involved in the maintenance of basal activity of the L-type Ca 2+ channel.
Functional difference between CaMKII and CaM in the recovery of the Ca 2+ channel activity from run-down In our previous study, we found that run-down of Ltype Ca 2+ channels had early and late phases (18) and that the early phase but not the late phase of run-down could be reversed by CaM + ATP (18) . In the present study, we have found that CaMKII together with CaM + ATP can reverse the late phase of run-down more effectively than CaM + ATP. These results suggest that CaMKII activity is required in the late-phase recovery of the channel activity.
The result that AIP blocked the recovery of the channel activity induced by CaMKII + CaM + ATP at 5 min but not at 1 min after run-down revealed that perhaps both CaMKII phosphorylation and direct CaM binding with the channel are required in the maintenance of basal activity of the Ca 2+ channels. We proposed the model shown in Fig. 6B . In the basal condition, a site of the channel (or related proteins) is phosphorylated (yellow circle) and CaM (red circle) is bound with the channel. When the inside-out patch is formed in the basic internal solution, in the early phase (1 min), CaM dissociates from the channel, but the channel is still in a phosphorylated state. Therefore, CaMKII inhibitor did not block the recovery induced by CaMKII + CaM + ATP. However, in the late phase (~5 min), the channel is dephosphorylated perhaps due to a membrane-bound phosphatase. To recover the channel activity in the late phase requires both CaM and CaMKII, and CaMKII inhibitor could block this recovery induced by CaMKII + CaM + ATP.
It is reported that CaM can bind directly to certain regions of the Ca 2+ -channel, including the N-terminal (35), the IQ motif, and the CB domain in the C-terminal tail of the α 1 subunit, and thereby regulates Ca 2+ -channel activity (14, 16, 17) . We have found that CaM and CaMKII have distinct roles in CDF and CDI: CaM is a key molecule to bifurcate the Ca 2+ signal to CDF and CDI, while CaMKII plays a modulatory role (36). Our present hypothesis about the maintenance of basal activity is in line with the view that CaMKII-mediated phosphorylation determines the channel activity (13) , and is consistent with the time-dependent attenuation of the CaM's effect (18) , provided that the CaMKII phosphorylation site is slowly dephosphorylated during run-down.
Possible mechanism of the run-down of Ca 2+ channels Previous studies showed that calpastatin + ATP partially restored channel activity from run-down (19% of control activity) (3, 9, 10) , while the calpastatin + ATP + H fraction reversed run-down nearly completely in guinea-pig ventricular myocytes (87%) (3), and that crude or partially purified cytoplasm extract of bovine heart (7, 8) also reversed run-down with relatively higher efficacy in guinea-pig ventricular myocyte (72% -90%). Furthermore, patch-cramming of the Xenopus oocyte expressed with exogenous Ca 2+ channel also reversed the run-down up to 73% (37). Romanin et al. also reported that calpastatin together with ATP and GTP effectively prevented run-down, but barely reversed channel activity after run-down occurred (38, 39). On the other hand, CaM + ATP reversed the rundown of the channel when applied during the earlier stage of patch-excision (18), while CaM + ATP together with CaMKII reversed run-down even at 5 min after the start of run-down (this study). These findings seem to be consistent with the proposal that the reversal of rundown induced by channel-activating factors such as calpastatin and CaM is neither complete nor persistent. CaMKII-mediated phosphorylation, which we found is required for the maintenance of basal activity of the channel, seems to be crucial for a complete reversal of run-down of L-type Ca 2+ channels. Additionally, PIP 2 has been reported to be crucial for maintaining the activity of many types of channels, including P/ Q-and N-type Ca 2+ channels (5) . Further studies showed that the change of a single amino acid (I1520) at the intracellular end of III-S6 in the α 1 subunit of P / Q-type Ca 2+ channels with histidine or aspartate greatly attenuated channel run-down in inside-out patch-clamp recordings and the attenuation of run-down is accompanied by an increase in apparent affinity for PIP 2 (6) .
However, the detailed mechanisms by which these factors prevent or reverse run-down and the interrelations of these mechanisms still need further studies. 
